Tokio Marine Asset Management Co. Ltd. increased its stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 11.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,900 shares of the biotechnology company’s stock after purchasing an additional 1,300 […]
Louisiana State Employees Retirement System raised its holdings in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 14.0% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 70,900 shares of the biotechnology company’s stock after acquiring an additional 8,700 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Ironwood Pharmaceuticals were […]
JMP Securities began coverage on shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) in a research report released on Thursday, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $22.00 target price on the biotechnology company’s stock. Other equities analysts also recently issued reports about the company. StockNews.com downgraded Ironwood Pharmaceuticals from a […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Equities research analysts at Zacks Research lifted their Q2 2025 earnings per share estimates for shares of Ironwood Pharmaceuticals in a report issued on Monday, September 25th. Zacks Research analyst A. Chakraborty now forecasts that the biotechnology company will post earnings of $0.23 per share for the […]
Duality Advisers LP lessened its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 54.9% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 33,811 shares of the biotechnology company’s stock after selling 41,198 shares during the period. Duality Advisers LP’s holdings in Ironwood Pharmaceuticals were worth […]